Reumatoloxía

2019

1. 2018 update of the EULAR recommendations for the management of hand osteoarthritis

   Annals of the Rheumatic Diseases, Vol. 78, Núm. 1, pp. 16-24

2. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

   Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1151-1159

3. A Phase II Trial of Lutikizumab, an Anti–Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis

   Arthritis and Rheumatology, Vol. 71, Núm. 7, pp. 1056-1069

4. A combined transcriptomic and genomic analysis identifies a gene signature associated with the response to anti-TNF therapy in rheumatoid arthritis

   Frontiers in Immunology, Vol. 10, Núm. JUL

5. Abatacept for the treatment of rheumatoid arthritis

   Expert Review of Clinical Immunology, Vol. 15, Núm. 4, pp. 319-326

6. Adherence to biological therapies in patients with chronic inflammatory arthropathies

   Farmacia Hospitalaria, Vol. 43, Núm. 4, pp. 134-139

7. Adherence to synthetic disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Results of the OBSERVAR Study

   Reumatologia Clinica, Vol. 15, Núm. 5, pp. 264-270

8. Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases

   Biochemical Pharmacology, Vol. 165, pp. 196-206

9. Analysis of endogenous peptides released from osteoarthritic cartilage unravels novel pathogenic markers

   Molecular and Cellular Proteomics, Vol. 18, Núm. 10, pp. 2018-2028

10. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

    American Journal of Ophthalmology, Vol. 200, pp. 85-94

11. Anti-inflammatory effects of novel standardized platelet rich plasma releasates on knee osteoarthritic chondrocytes and cartilage in vitro

    Current Pharmaceutical Biotechnology, Vol. 20, Núm. 11, pp. 920-933

12. Artrocentesis

    Normas de actuación en urgencias (Editorial Médica Panamericana), pp. 743-746

13. Association of Functional Polymorphisms of KIR3DL1/DS1 With Behçet's Disease

    Frontiers in Immunology, Vol. 10

14. Behçet’s disease and genetic interactions between HLA-B*51 and variants in genes of autoinflammatory syndromes

    Scientific Reports, Vol. 9, Núm. 1

15. Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British Cohort

    BMJ Open, Vol. 9, Núm. 6

16. Cervicalgia

    Normas de actuación en urgencias (Editorial Médica Panamericana), pp. 528-531

17. Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR

    Clinical Rheumatology, Vol. 38, Núm. 8, pp. 2129-2139

18. Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study

    Rheumatology International, Vol. 39, Núm. 12, pp. 2015-2024

19. Commercially available antibiotic-laden PMMA-covered locking nails for the treatment of fracture-related infections - A retrospective case analysis of 10 cases

    Journal of Bone and Joint Infection, Vol. 4, Núm. 4, pp. 155-162

20. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

    Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089